Vor Biopharma Inc. (VOR)
NASDAQ: VOR
· Real-Time Price · USD
2.13
0.15 (7.58%)
At close: Aug 15, 2025, 3:59 PM
2.12
-0.24%
After-hours: Aug 15, 2025, 07:58 PM EDT
Vor Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.66B | -118.6M | -116.91M | -112.46M | -118.09M | -120.23M | -117.86M | -115.51M | -106.11M | -97.79M | -92.09M | -86.44M | -81.2M | -77.91M | -68.9M | -66.31M | -59.54M | -49.21M |
Depreciation & Amortization | 4.55M | 3.38M | 3.5M | 3.52M | 1.28M | 3.6M | 3.49M | 3.23M | 5.55M | 2.94M | 2.52M | 2.29M | 1.77M | 1.55M | 1.43M | 1.28M | 1.1M | 850K |
Stock-Based Compensation | 7.75M | 8.7M | 9.85M | 10.03M | 10.93M | 12.38M | 13.36M | 15.35M | 15.51M | 13.02M | 10.7M | 8.02M | 5.84M | 5.17M | 4.32M | 3.71M | 3.04M | 2.12M |
Other Working Capital | 813K | -1.86M | -2.24M | -2.32M | -3.12M | -2.44M | -709K | -957K | -1.37M | -9.46M | -12.15M | -13.18M | -12.48M | -6.74M | -7.15M | -9.86M | -6.21M | -6.1M |
Other Non-Cash Items | 1.53B | 4.77M | 3.9M | 6.38M | 1.93M | -3.23M | -2.92M | -4.4M | 304K | 6.19M | 6.42M | 5.06M | 4.32M | 3.85M | 3.19M | 2.62M | 2.15M | 1.1M |
Deferred Income Tax | n/a | n/a | n/a | -3.51M | 1.94M | 2.98M | 2.98M | 6.49M | 1.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.71M | 1.49M | 5K | -3.59M | -2.22M | -1.98M | 650K | 230K | -1.91M | -10.86M | -12.69M | -13.32M | -13.55M | -7.06M | -9.19M | -6.49M | -2.84M | -2.72M |
Operating Cash Flow | -113.6M | -100.26M | -99.66M | -99.62M | -104.24M | -106.49M | -100.29M | -94.61M | -85.62M | -86.51M | -85.14M | -84.39M | -82.83M | -74.4M | -69.14M | -65.19M | -56.09M | -47.86M |
Capital Expenditures | -489K | -346K | -229K | -268K | -699K | -1.09M | -1.07M | -1.28M | -1.11M | -6.54M | -8.46M | -9.31M | -9.65M | -4.73M | -3.89M | -4.2M | -5.15M | -4.79M |
Cash Acquisitions | 799K | n/a | n/a | n/a | -41K | -55.04K | -61.63K | 35.09K | 76.08K | 90.12K | 96.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -1K | -9.91M | -26.47M | -26.47M | -61.43M | -74.92M | -176.51M | -176.51M | -141.55M | -123.19M | -9.83M | -17.68M | -92.8M | -87.76M | -82.97M | -75.12M | n/a |
Sales Maturities Of Investments | n/a | 53M | 107M | 134M | 175M | 171M | 147M | 141.43M | 113.43M | 67.56M | 37.56M | 16.13M | 3.13M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 41K | 55.04K | 61.63K | -35.09K | -63.09K | -73.99K | -5.12M | -9.81M | -17.68M | -92.8M | -87.76M | -82.97M | -75.12M | n/a |
Investing Cash Flow | 310K | 52.65M | 96.86M | 107.26M | 147.83M | 108.48M | 71.01M | -36.36M | -64.2M | -80.54M | -94.09M | -3.01M | -24.2M | -97.53M | -91.65M | -87.17M | -80.28M | -4.79M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -32K | n/a | n/a | n/a | n/a | n/a | -400K | -400K | -400K | -400K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 228.63M | 53.52M | 53.39M | -263K | -409K | -719K | -1.64M | -1.05M | -599K | -138K | 1.17M | 842K | 809K | 264K | -1.66M | -1.92M | -1.97M | -1.51M |
Financial Cash Flow | 227.79M | 52.69M | 53.39M | 131K | 266K | 515K | 2.94M | 115.17M | 119.07M | 119.46M | 117.14M | 5.19M | 1.31M | 263K | 232.91M | 232.65M | 232.97M | 297.61M |
Net Cash Flow | 114.5M | 5.08M | 50.59M | 7.77M | 43.86M | -25.46M | -54.32M | -43.77M | -58.71M | -47.59M | -62.09M | -82.21M | -105.71M | -171.67M | 72.12M | 80.28M | 96.61M | 244.97M |
Free Cash Flow | -114.09M | -100.61M | -99.89M | -99.89M | -104.94M | -107.58M | -101.36M | -95.89M | -86.73M | -93.05M | -93.61M | -93.69M | -92.47M | -79.13M | -73.04M | -69.39M | -61.25M | -52.64M |